 pharmacokinet didanosin patient acquir immunodefici syndrom immunodefici syndrome-rel complex pharmacokinet didanosin intraven oral administr open escalating-dos phase patient acquir immunodefici syndrom aid sever aids-rel complex didanosin day week intraven infus minut durat dose mg/kg week oral treatment intraven dose serial blood urin sampl first final day intraven administr first oral dose steadi state didanosin linear pharmacokinet behavior dose rang mg/kg mg/kg indic signific chang pharmacokinet paramet repeat administr appar elimin half-lif oral administr hour renal clearanc valu glomerular filtrat rate activ tubular secret didanosin occur bioavail didanosin solut antacid dose mg/kg patient aid aids-rel complex bioavail didanosin citrate-phosphate-buff solut formul phase II access studi compar formul phase trial